UBS O'Connor’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

UBS O'Connor’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,732,445	Closed	-$17.1M	–	839
2022 Q3	$17.1M	Hold	1,732,445	–	–	0.19%	62
2022 Q2	$17M	Buy	+1,732,445	New	+$17M	0.18%	66
2022 Q1	–	Sell	-1,732,445	Closed	-$17M	–	706
2021 Q4	$17M	Hold	1,732,445	–	–	0.16%	57
2021 Q3	$16.9M	Hold	1,732,445	–	–	0.13%	67
2021 Q2	$16.7M	Hold	1,732,445	–	–	0.15%	59
2021 Q1	$16.6M	Buy	+1,732,445	New	+$16.8M	0.24%	57

UBS O'Connor's SHAC Position: Q4 2022 in Review

UBS O'Connor sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 1,732,445 shares — an estimated $17.1M sold.

UBS O'Connor first reported a position in SHAC in Q1 2021 and held it in 6 quarters. The position peaked at $17.1M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

UBS O'Connor reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 1,732,445 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $17.1M.
UBS O'Connor first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 6 quarters.
UBS O'Connor's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $17.1M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.